相关实验视频

Updated: Jun 7, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.2K

免疫检查点抑制剂是否会影响多发性硬化症的过程? 一个系统的审查和元分析

Stefano Gelibter1, Lorenzo Saraceno1, Emanuela Susani1

  • 1Department of Neurosciences, Neurology and Stroke Unit, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, Italy.

European journal of neurology
|November 18, 2024
PubMed
概括

免疫检查点抑制剂 (ICI) 在多发性硬化症 (pwMS) 患者,特别是老年人中,复发率较低. 然而,神经辐射活动可能会增加,特别是如果停止改变疾病的治疗.

关键词:
核磁共振扫描 (MRI) 损伤疾病活动的疾病活动.免疫检查点抑制剂 免疫检查点抑制剂多发性硬化症多发性硬化症这是一个复发的复发.

更多相关视频

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.5K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

759

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142